A weight loss drug maker is aiming for a big IPO
In This Story NVO LLY MS VKTX RHHBY PFE BioAge Labs, a biopharmaceutical startup focused on obesity drugs, is looking to raise nearly $200 million in its recently expanded, planned initial public offering, according to a filing with the U.S. Securities and Exchange Commission (SEC). Suggested Reading Trump Media stock surges as Donald Trump holds onto his shares Elon Musk criticizes censorship, but his X grants more government requests than Twitter did How Kamala Harris and Donald Trump would
din zilele anterioare